Cutting Edge Cancer Treatment Now Available With Opening of CyberKnife Center of Tampa Bay
Posted on: Monday, 28 July 2008, 09:01 CDT
TAMPA, Fla., July 28 /PRNewswire/ -- Cutting edge cancer treatment is now available in Tampa Bay. The first of its kind in the region, the CyberKnife Center will serve as an open outpatient cancer and tumor treatment center available for use by all physicians, surgeons and patients who wish to utilize the revolutionary technology.
CyberKnife(R) is the world's first and only robotic radiosurgical system designed to deliver high doses of targeted radiation to tumors almost anywhere in the body with sub-millimeter accuracy. It is especially effective at reaching and treating very small tumors and lesions. It has proven to be successful with lung cancer, prostate, intracranial, neck, liver, and pancreas.
The treatment has revolutionized cancer treatment for specifically qualified patients. The benefits of CyberKnife are:
-- non invasive -- can be completed in 1-5 treatments -- no pain -- no incision -- patient resumes normal activity immediately
Tampa Bay Radiosurgical Associates, LLC will own, manage and operate the center in the Town and Country area of Tampa, adjacent to Town and Country Hospital. The Managing Director is Dr. James G. Schwade and principals are Dr. Randy Kahn, Dr. Jack Steel, Dr. Harvey Greenberg, Dr. Frank Franzese, Dr. Bob Miller and Dr. Zucel Solc.
For more information please visit http://www.morsecyberknife.com/ to learn more about CyberKnife treatment at one of our facilities or call 1-813-884-7400 and 1-800-204-0455.
Tampa Bay Radiosurgical Associates, LLC
CONTACT: Susan Nefzger of Susan Nefzger PR & Web Marketing for Tampa BayRadiosurgical Associates, LLC, +1-561-632-9525
Web site: http://www.morsecyberknife.com/
Source: PRNewswire
Related Articles
- MedCath Sells Sun City Cardiac Center Associates to Banner Health
- Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
- A Growing Number of Brits Cross the Atlantic for Donor Egg IVF Treatment at Shady Grove Fertility Center
- San Antonio-based Academy Diagnostics LLC Sleep Center Achieves National Accreditation
- U.S. Food and Drug Administration Approves ABILIFY(R) (Aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
- Norditropin(R) Approved for Treatment of Children With Short Stature Associated With Turner Syndrome
- Major Milestones Announced for Sonablate 500 HIFU Treatment of Prostate Cancer at Annual American Urology Association Conference
- $20 Million Gift to Establish Cancer Stem Cell Research Center at Stanford
- Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic Antibody-Associated Small-Vessel Vasculitis
- Immunicon Corporation Announces Presentation of Data on Circulating Tumor Cells in 'Non-Measurable' Metastatic Breast Cancer at the 2005 American Association of Clinical Oncology (ASCO) Annual Meeting
 |
 |
User Comments (0)
RSS Feeds